Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
Eduardo Mysler, Mariana Caubet, Ana Lizarraga Organización Medica de Investigación, Buenos Aires, ArgentinaCorrespondence: Eduardo Mysler Email e.mysler@omiargentina.com.arAbstract: Rheumatoid arthritis (RA) is the most prevalent form of inflammatory arthritis. It is a profound...
Enregistré dans:
Auteurs principaux: | Mysler E, Caubet M, Lizarraga A |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/45b1d4dc816145d7b84c99f4c59ddaae |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Management of rheumatoid arthritis during pregnancy: challenges and solutions
par: Krause ML, et autres
Publié: (2016) -
Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South‐Western Saudi Arabia: A Retrospective Study
par: AlOmair M, et autres
Publié: (2021) -
Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
par: Lurati A, et autres
Publié: (2021) -
Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
par: Ulusoy H, et autres
Publié: (2020) -
The onset of rheumatoid arthritis following trauma
par: Brawer AE, et autres
Publié: (2016)